Autopsy report · NCT00517582

Bradykinin Receptor Blocker in ACE Inhibitor-associated Angioedema

“This study was stopped to allow initiation of a mult-center study”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 8 years 3 months before it stopped.
• 13 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Vanderbilt University

Sponsor type

University, hospital or other

Conditions

Angioneurotic Edema

Interventions

HOE-140; Placebo

Participants

13

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.